Circular RNAs in acute myeloid leukemia
Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical proble...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e69252ad152d4db9abeb3705116de2f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e69252ad152d4db9abeb3705116de2f9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e69252ad152d4db9abeb3705116de2f92021-11-21T12:02:26ZCircular RNAs in acute myeloid leukemia10.1186/s12943-021-01446-z1476-4598https://doaj.org/article/e69252ad152d4db9abeb3705116de2f92021-11-01T00:00:00Zhttps://doi.org/10.1186/s12943-021-01446-zhttps://doaj.org/toc/1476-4598Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While current diagnostic modalities are primarily defined by gross morphology, cytogenetics, and to an extent, by deep targeted gene sequencing, there is an ongoing demand to identify newer diagnostic, therapeutic and prognostic biomarkers for AML. Recent interest in exploring the role of circular RNA (circRNA) in elucidating AML biology and therapy resistance has been promising. This review discerns the circular RNAs’ evolving role on the same scientific premise and attempts to identify its potential in managing AML.Vijendra SinghMohammed Hafiz UddinJeffrey A. ZonderAsfar S. AzmiSuresh Kumar BalasubramanianBMCarticleAcute myeloid leukemiaNon-coding RNACircular RNANeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENMolecular Cancer, Vol 20, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Acute myeloid leukemia Non-coding RNA Circular RNA Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Acute myeloid leukemia Non-coding RNA Circular RNA Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Vijendra Singh Mohammed Hafiz Uddin Jeffrey A. Zonder Asfar S. Azmi Suresh Kumar Balasubramanian Circular RNAs in acute myeloid leukemia |
description |
Abstract Although mechanistic studies clarifying the molecular underpinnings of AML have facilitated the development of several novel targeted therapeutics, most AML patients still relapse. Thus, overcoming the inherent and acquired resistance to current therapies remains an unsolved clinical problem. While current diagnostic modalities are primarily defined by gross morphology, cytogenetics, and to an extent, by deep targeted gene sequencing, there is an ongoing demand to identify newer diagnostic, therapeutic and prognostic biomarkers for AML. Recent interest in exploring the role of circular RNA (circRNA) in elucidating AML biology and therapy resistance has been promising. This review discerns the circular RNAs’ evolving role on the same scientific premise and attempts to identify its potential in managing AML. |
format |
article |
author |
Vijendra Singh Mohammed Hafiz Uddin Jeffrey A. Zonder Asfar S. Azmi Suresh Kumar Balasubramanian |
author_facet |
Vijendra Singh Mohammed Hafiz Uddin Jeffrey A. Zonder Asfar S. Azmi Suresh Kumar Balasubramanian |
author_sort |
Vijendra Singh |
title |
Circular RNAs in acute myeloid leukemia |
title_short |
Circular RNAs in acute myeloid leukemia |
title_full |
Circular RNAs in acute myeloid leukemia |
title_fullStr |
Circular RNAs in acute myeloid leukemia |
title_full_unstemmed |
Circular RNAs in acute myeloid leukemia |
title_sort |
circular rnas in acute myeloid leukemia |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/e69252ad152d4db9abeb3705116de2f9 |
work_keys_str_mv |
AT vijendrasingh circularrnasinacutemyeloidleukemia AT mohammedhafizuddin circularrnasinacutemyeloidleukemia AT jeffreyazonder circularrnasinacutemyeloidleukemia AT asfarsazmi circularrnasinacutemyeloidleukemia AT sureshkumarbalasubramanian circularrnasinacutemyeloidleukemia |
_version_ |
1718419337245622272 |